(a) Profile of IL-33 in patients showing highest level of expression of IL-33 at month 0, month 6–9 and month 12–15 (b) cross sectional analysis of IL-33 levels between MS patients after relapse and in OND patients.</p
<p>(<b>A</b>) Levels of cytokines differentially expressed between N2 and MM were evaluated as a fun...
<div><p>(A) B-cell subpopulation analysis by flow cytometry. Peripheral blood mononuclear cell (PBMC...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
The Y axis shows the different therapies patients were maintained on during the 12 month period afte...
IL-33 expression levels were determined by PCR and normalized to expression levels of GAPDH. The X-a...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
<p>Quantitative-PCR to measure IL-22 mRNA expression (A) <i>ex vivo</i> (Relapsing MS: n = 56, Stabl...
Objectives: Interleukin (IL)-33 is a cytokine with both pro- and anti-inflammatory effects involved ...
<p>(<b>A</b>) Levels of cytokines differentially expressed between N2 and MM were evaluated as a fun...
<div><p>(A) B-cell subpopulation analysis by flow cytometry. Peripheral blood mononuclear cell (PBMC...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
The Y axis shows the different therapies patients were maintained on during the 12 month period afte...
IL-33 expression levels were determined by PCR and normalized to expression levels of GAPDH. The X-a...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
<p>Quantitative-PCR to measure IL-22 mRNA expression (A) <i>ex vivo</i> (Relapsing MS: n = 56, Stabl...
Objectives: Interleukin (IL)-33 is a cytokine with both pro- and anti-inflammatory effects involved ...
<p>(<b>A</b>) Levels of cytokines differentially expressed between N2 and MM were evaluated as a fun...
<div><p>(A) B-cell subpopulation analysis by flow cytometry. Peripheral blood mononuclear cell (PBMC...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...